Related Experiment Video
Updated: Mar 2, 2026
05:44
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
2.5K
Multiple sclerosis risk pathways differ in Caucasian and Chinese populations.
Guiyou Liu1, Fang Zhang2, Yang Hu1
1School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Journal of Neuroimmunology
|May 13, 2017
Summary
This study analyzed multiple sclerosis (MS) risk pathways using genome-wide association study (GWAS) data. We identified 31 differentially expressed genes in Chinese MS patients, with many showing patterns similar to Caucasian patients.
Area of Science:
- Genetics
- Immunology
- Neuroscience
Background:
- Genome-wide association studies (GWAS) are crucial for understanding multiple sclerosis (MS) mechanisms.
- Pathway analysis of GWAS and expression data can reveal key biological processes involved in MS.
- Genetic variations contribute to MS susceptibility across diverse ethnic populations.
Purpose of the Study:
- To identify and validate MS risk pathways and differentially expressed genes in the Chinese population.
- To compare gene expression patterns in Chinese MS patients with those in Caucasian MS patients.
- To provide insights into the genetic basis of MS susceptibility in China.
Main Methods:
- A three-stage pathway analysis integrating GWAS and gene expression datasets.
- Identification of shared MS risk pathways across independent GWAS datasets.
- Differential gene expression analysis of 42 MS-associated genes in 132 Chinese MS patients and 76 healthy controls.
Main Results:
- 15 shared MS pathways were identified, with 10 significantly enriched for dysregulated MS genes.
- 31 differentially expressed genes were found in Chinese MS patients.
- Expression patterns of 28 genes were consistent with Caucasian MS patients, while 14 differed.
Conclusions:
- The study identified specific MS risk pathways and differentially expressed genes relevant to the Chinese population.
- Genetic underpinnings of MS in Chinese patients show both similarities and differences compared to Caucasian populations.
- Findings offer clinically relevant information for understanding MS susceptibility in China.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
65
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
65
01:29Psychological and Sociocultural Causes of Schizophrenia
717
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
717
01:27Principles of Pharmacogenetics: Types of Genetic Variants
60
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
60
01:05Single Nucleotide Polymorphisms-SNPs
18.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.8K
01:11Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K